Australian Clinical Labs Ltd ACL Stock Quote
Morningstar‘s Stock Analysis ACL
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile ACL
Australian Clinical Labs Ltd is engaged in the provision of pathology services. Its services include all routine pathology tests, advanced pathology, First-trimester screening, and Non-Invasive prenatal testing, Chemical pathology, Haematology, Histopathology, Immunology, Serology and microbiology, Functional pathology, Commercial drug, and alcohol testing. The company has its operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
Clayton, VIC, 3168, Australia